Mislav Acman
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 2
- Antimicrobial Resistance in Staphylococcus 2
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Lucy van Dorp (9 shared papers)François Balloux (9 shared papers)Liam P. Shaw (5 shared papers)Cedric Tan (4 shared papers)Damien Richard (2 shared papers)Arturo Torres Ortiz (3 shared papers)Juanita Pang (3 shared papers)Louise Ormond (1 shared paper)
- Journals
- Nature Communications (3 papers)Microbial Genomics (2 papers)Genome Medicine (2 papers)Cancer Gene Therapy (1 paper)animal (1 paper)
- Partner nations
- United KingdomNorwayFrance
In The Last Decade
Mislav Acman
13 papers receiving 1.0k citations
Mislav Acman's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 649
- Molecular Medicine 172
- Modeling and Simulation 85
- Endocrinology 55
- Applied Microbiology and Biotechnology 18
Countries citing papers authored by Mislav Acman
This map shows the geographic impact of Mislav Acman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mislav Acman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mislav Acman more than expected).
Fields of papers citing papers by Mislav Acman
This network shows the impact of papers produced by Mislav Acman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mislav Acman. The network helps show where Mislav Acman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mislav Acman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 Hit paper breakdown → | 2020 | 520 |
| 2 | 2020 | 188 | |
| 3 | Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM Hit paper breakdown → | 2022 | 151 |
| 4 | 2020 | 78 | |
| 5 | 2021 | 45 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 21 | |
| 8 | 2021 | 6 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2021 | 1 |
About Mislav Acman
Mislav Acman is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Clinical Biochemistry and Molecular Medicine, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Plant Virus Research Studies (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Resistance in Bacteria (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Mycobacterium research and diagnosis (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Infectious Diseases (649 citations), Molecular Medicine (172 citations), Modeling and Simulation (85 citations), Endocrinology (55 citations) and Applied Microbiology and Biotechnology (18 citations). Mislav Acman has collaborated with scholars based in United Kingdom, Norway and France. Frequent co-authors include Lucy van Dorp, François Balloux, Liam P. Shaw, Cedric Tan, Damien Richard, Arturo Torres Ortiz, Juanita Pang, Louise Ormond, Charlotte Ford and C. J. Owen. Their work appears in journals such as Nature Communications, Microbial Genomics, Genome Medicine, Cancer Gene Therapy and animal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.